Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Operating Margin for Allogene Therapeutics (ALLO)
Operating Margin as of May 2024 (TTM): -151,507.00%
According to Allogene Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -151,507.00%. At the end of 2021 the company had an Operating Margin of -667.74%.
Operating Margin history for Allogene Therapeutics from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -667.74% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.